We’re sticking with Dr Martens despite the latest profit warning
Dr. Martens (DOCS) 72.1pLoss to date: 21.6%In mid-December 2023 we said the knock-down share price of iconic footwear brand Dr. Martens (DOCS) was too tempting to resist despite the company delivering four profit warnings.Our rationale was simple ? either the self-inflicted operational issues would be fixed by the current management or the business would be taken over by an opportunistic predator